These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 19906308)

  • 1. Variables that influence HIV-1 cerebrospinal fluid viral load in cryptococcal meningitis: a linear regression analysis.
    Cecchini DM; Cañizal AM; Rojas H; Arechavala A; Negroni R; Bouzas MB; Benetucci JA
    J Int AIDS Soc; 2009 Nov; 12():33. PubMed ID: 19906308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors influencing cerebrospinal fluid and plasma HIV-1 RNA detection rate in patients with and without opportunistic neurological disease during the HAART era.
    Christo PP; Greco DB; Aleixo AW; Livramento JA
    BMC Infect Dis; 2007 Dec; 7():147. PubMed ID: 18096083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrospinal fluid viral load, intrathecal immunoactivation, and cerebrospinal fluid monocytic cell count in HIV-1 infection.
    Gisslén M; Fuchs D; Svennerholm B; Hagberg L
    J Acquir Immune Defic Syndr; 1999 Aug; 21(4):271-6. PubMed ID: 10428104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-17 mediated differences in the pathogenesis of HIV-1-associated tuberculous and cryptococcal meningitis.
    Marais S; Meintjes G; Lesosky M; Wilkinson KA; Wilkinson RJ
    AIDS; 2016 Jan; 30(3):395-404. PubMed ID: 26765934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-1 RNA levels in cerebrospinal fluid and plasma and their correlation with opportunistic neurological diseases in a Brazilian AIDS reference hospital.
    Christo PP; Greco DB; Aleixo AW; Livramento JA
    Arq Neuropsiquiatr; 2005 Dec; 63(4):907-13. PubMed ID: 16400403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of Human Immunodeficiency Virus Viral Load in Cerebrospinal Fluid and Plasma in Patients Co-infected With Cryptococcal Meningitis.
    Chang CC; Kangethe R; Omarjee S; Hiramen K; Gosnell B; Sojane K; Moosa MS; Lewin SR; French MA; Ndung'u T
    Open Forum Infect Dis; 2017; 4(2):ofx032. PubMed ID: 28470016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetics of HIV-1 in cerebrospinal fluid and plasma in cryptococcal meningitis.
    Cecchini DM; Cañizal AM; Rojas H; Arechavala A; Negroni R; Bouzas MB; Benetucci JA
    Infect Dis Rep; 2012 Apr; 4(2):e30. PubMed ID: 24470944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal fluid levels of chemokines in HIV infected patients with and without opportunistic infection of the central nervous system.
    Christo PP; Vilela Mde C; Bretas TL; Domingues RB; Greco DB; Livramento JA; Teixeira AL
    J Neurol Sci; 2009 Dec; 287(1-2):79-83. PubMed ID: 19782379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The utility of cerebrospinal fluid white cell count during the prognostic assessment for cryptococcal meningitis patients: a retrospective study.
    Qu J; Jiang J; Lv X
    BMC Infect Dis; 2020 Aug; 20(1):571. PubMed ID: 32758162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of CSF HIV-1 Escape during Treatment of HIV-Associated Cryptococcal Meningitis in Botswana.
    Kelentse N; Moyo S; Molebatsi K; Morerinyane O; Bitsang S; Bareng OT; Lechiile K; Leeme TB; Lawrence DS; Kasvosve I; Musonda R; Mosepele M; Harrison TS; Jarvis JN; Gaseitsiwe S
    Biomedicines; 2022 Jun; 10(6):. PubMed ID: 35740421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of correlation between cerebrospinal fluid and plasma HIV-1 RNA levels in patients with neurological opportunistic diseases.
    Christo PP; Greco DB; Aleixo AW; Livramento JA
    Rev Inst Med Trop Sao Paulo; 2011; 53(4):193-6. PubMed ID: 21915461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV infection of the central nervous system is characterized by rapid turnover of viral RNA in cerebrospinal fluid.
    Eggers CC; van Lunzen J; Buhk T; Stellbrink HJ
    J Acquir Immune Defic Syndr Hum Retrovirol; 1999 Mar; 20(3):259-64. PubMed ID: 10077174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of ventriculoperitoneal shunts for uncontrollable intracranial hypertension in patients with HIV-associated cryptococcal meningitis with or without hydrocephalus.
    Liu L; Zhang R; Tang Y; Lu H
    Biosci Trends; 2014 Dec; 8(6):327-32. PubMed ID: 25641179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokine patterns in a prospective cohort of HIV-infected patients with cryptococcal meningitis following initiation of antifungal and antiretroviral therapy.
    Mora DJ; Ferreira-Paim K; Andrade-Silva LE; Bragine T; Rocha IH; Ribeiro BM; Machado GH; Rodrigues Junior V; Silva-Teixeira DN; Meyer W; Silva-Vergara ML
    PLoS One; 2017; 12(5):e0176304. PubMed ID: 28486489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk Factors for CSF/Plasma HIV-1 RNA Discordance in HIV-Infected Patients.
    Nie J; Zeng Y; Zeng Q; Du X; Chen Y
    J Acquir Immune Defic Syndr; 2022 Oct; 91(S1):S20-S26. PubMed ID: 36094511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual R3R5 tropism characterizes cerebrospinal fluid HIV-1 isolates from individuals with high cerebrospinal fluid viral load.
    Karlsson U; Antonsson L; Ljungberg B; Medstrand P; Esbjörnsson J; Jansson M; Gisslen M
    AIDS; 2012 Sep; 26(14):1739-44. PubMed ID: 22695299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delayed central nervous system virus suppression during highly active antiretroviral therapy is associated with HIV encephalopathy, but not with viral drug resistance or poor central nervous system drug penetration.
    Eggers C; Hertogs K; Stürenburg HJ; van Lunzen J; Stellbrink HJ
    AIDS; 2003 Sep; 17(13):1897-906. PubMed ID: 12960822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebrospinal fluid HIV-1 RNA levels in asymptomatic patients with early stage chronic HIV-1 infection: support for the hypothesis of local virus replication.
    García F; Niebla G; Romeu J; Vidal C; Plana M; Ortega M; Ruiz L; Gallart T; Clotet B; Miró JM; Pumarola T; Gatell JM
    AIDS; 1999 Aug; 13(12):1491-6. PubMed ID: 10465072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of cryptococcal antigen lateral flow assay in serum, cerebrospinal fluid, whole blood, and urine in HIV-infected patients with culture-proven cryptococcal meningitis admitted at a Brazilian referral center.
    Vidal JE; Toniolo C; Paulino A; Colombo AL; Martins MDA; Meira CDS; Azevedo RGS; Pereira-Chioccola VL; Gomes HR; Lazera MDS; Oliveira ACP; Boulware DR
    Rev Inst Med Trop Sao Paulo; 2018; 60():e1. PubMed ID: 29451598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparisons of clinical features and mortality of cryptococcal meningitis between patients with and without human immunodeficiency virus infection.
    Lee YC; Wang JT; Sun HY; Chen YC
    J Microbiol Immunol Infect; 2011 Oct; 44(5):338-45. PubMed ID: 21524972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.